>
Analytica logo

ALT - Analytica Share Price

A$0.004 0.0  14.3%

Last Trade - 09/04/21

Sector
Healthcare
Size
Micro Cap
Market Cap £7.84m
Enterprise Value £8.10m
Revenue £481k
Position in Universe 1634th / 1893
Bullish
Bearish
Unlock ALT Revenue
Momentum
Relative Strength (%)
1m +27.7%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -33.3%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
1.12 2.12 1.25 1.01 0.83 0.81 -6.3%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 31 December 2020, AnalyticaLimited revenues increased 7% to A$781K. Net loss increased11% to A$450K. Revenues reflect Royalty Income increase of37% to A$8K. Higher net loss reflects Research anddevelopment expense increase of 8% to A$699K (expense),Option expenses decrease from A$49K (income) to A$0K,Administration expense increase of 10% to A$452K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ALT Revenue Unlock ALT Revenue

Net Income

ALT Net Income Unlock ALT Revenue

Normalised EPS

ALT Normalised EPS Unlock ALT Revenue

PE Ratio Range

ALT PE Ratio Range Unlock ALT Revenue

Dividend Yield Range

ALT Dividend Yield Range Unlock ALT Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
ALT EPS Forecasts Unlock ALT Revenue
Profile Summary

Analytica Limited is engaged in the design, development and supply of Class I and II medical devices. The Company's segments include Medical devices and Corporate. The Medical devices segment's products include PeriCoach (Perineometer), ELF-2 and AutoStart burette. The Company's lead product is the PeriCoach System, an e-health treatment system for women suffering from stress urinary incontinence. PeriCoach includes a device, Web portal and smartphone application. The device evaluates activity in pelvic floor muscles. The information is transmitted to a smartphone application and can be loaded to PeriCloud where physicians can monitor patient progress through Web portal. The Analytica Autostart Infusion System offers solution to regular monitoring and refilling of burettes in intravenous fluid infusion. The Autostart burette contains a float system that automatically restarts intra-venous (IV) fluid flow following infused delivery of the predetermined amount of a required medication.

Directors
Last Annual June 30th, 2020
Last Interim December 31st, 2020
Incorporated August 27, 1985
Public Since October 25, 2000
No. of Shareholders: n/a
No. of Employees: 2
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange Australian Stock Exchange - SEATS
Shares in Issue 3,519,612,332
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ALT Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ALT
Upcoming Events for ALT
Frequently Asked Questions for Analytica
What is the Analytica share price?

As of 09/04/21, shares in Analytica are trading at A$0.004, giving the company a market capitalisation of £7.84m. This share price information is delayed by 15 minutes.

How has the Analytica share price performed this year?

Shares in Analytica are currently trading at A$0.004 and the price has moved by 100% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Analytica price has moved by 50% over the past year.

What are the analyst and broker recommendations for Analytica?

There are no analysts currently covering Analytica.

When will Analytica next release its financial results?

Analytica is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Analytica dividend yield?

Analytica does not currently pay a dividend.

Does Analytica pay a dividend?

Analytica does not currently pay a dividend.

When does Analytica next pay dividends?

Analytica does not currently pay a dividend.

How do I buy Analytica shares?

To buy shares in Analytica you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Analytica?

Shares in Analytica are currently trading at A$0.004, giving the company a market capitalisation of £7.84m.

Where are Analytica shares listed? Where are Analytica shares listed?

Here are the trading details for Analytica:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: ALT
What kind of share is Analytica?

Based on an overall assessment of its quality, value and momentum, Analytica is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Analytica share price forecast 2021?

We were not able to load any forecast data for Analytica.

How can I tell whether the Analytica share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Analytica. Over the past six months, the relative strength of its shares against the market has been 16.62%. At the current price of A$0.004, shares in Analytica are trading at 35.14% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Analytica PE Ratio?

We were not able to find PE ratio data for Analytica.

Who are the key directors of Analytica?

Analytica's management team is headed by:

Bryan Dulhunty - CFO
Michael Monsour - CHM
Geoff Daly - CEO
Ross Mangelsdorf - NID
Peter Corr - DRC
Who are the major shareholders of Analytica?

Here are the top five shareholders of Analytica based on the size of their shareholding:

Inov8 LLC Corporation
Percentage owned: 10.25% (360.8m shares)
Ignatius Lip Pty. Ltd. Corporation
Percentage owned: 4.29% (151.1m shares)
Mullins (Teresa Margaret) Individual Investor
Percentage owned: 2.92% (102.8m shares)
Arundel (Mark Overell Tagg) Individual Investor
Percentage owned: 1.96% (69.1m shares)
Van Am Marketing Pty. Ltd. Corporation
Percentage owned: 1.94% (68.4m shares)
Similar to ALT
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.